Suppliers / Hill Dermaceuticals

Hill Dermaceuticals

United States 60 employees Updated 9 July 2026

Hill Dermaceuticals is a finished-dose manufacturer based in United States. It appears in 19 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, ARCSA (EC) and MINSA (CR). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 14 October 2025 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
19
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 14 October 2025 VAI US FDA
  • 11 August 2021 VAI US FDA
  • 18 May 2018 VAI US FDA
  • 6 October 2014 VAI US FDA
  • 10 August 2012 OAI US FDA
  • 30 March 2012 OAI US FDA
  • 10 September 2010 OAI US FDA
  • 19 February 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Sanford, United Arab Emirates Not on file
SANFORD, United States 1036365

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 14 None
ARCSA (EC) 1 None
MINSA (CR) 1 None
US FDA 1 1
EDE (AE) 1 None
NPRA (MY) 1 None

Questions about Hill Dermaceuticals

Does Hill Dermaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Hill Dermaceuticals. It does have 19 filings with 6 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Hill Dermaceuticals FDA-registered?
One site operated by Hill Dermaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Hill Dermaceuticals's last inspection go?
The most recent inspection on record closed on 14 October 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file, of which 3 closed as OAI.
Where does Hill Dermaceuticals manufacture?
2 registered sites are on record, in United Arab Emirates and United States (Sanford and Sanford). Every site is listed on this page with the register it came from.
Which regulators recognise Hill Dermaceuticals's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Hill Dermaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 October 2025.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates